Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > All time low!
View:
Post by Dumbeldorfwhite on Nov 13, 2023 10:31am

All time low!

Congrats! Great job everybody, took a lot of hardwork to get here
Comment by N0taP00p on Nov 13, 2023 11:17am
I guess would-be investors are not buying the story so easily, given the stellar execution and communication history.   Either it's the opportunity of a lifetime or this company will soon become a seller of IP at firesale prices. I want to believe the former but at this point, anything is a bonus.  
Comment by Dumbeldorfwhite on Nov 13, 2023 12:16pm
Remember when we had a head of business development getting paid a hefty salary IMO....
Comment by gebremeskel on Nov 13, 2023 1:23pm
The soft bashers are getting bolder. They think they smell blood but Theralase is not actually wounded. We're very close to undeniable success in this trial. A small cash infusion should be enough to bring us over the line. We are on the verge of proving this treatment is the best option available for bcg unresponsive NMIBC and there is much more to follow.
Comment by m8magic on Nov 13, 2023 2:05pm
this will be fine...BABY got knocked down to 18 cents from the sixties and is back up...all in a month...same will happen with TLT with news after the financing
Comment by chry200030 on Nov 13, 2023 2:36pm
Let's not forget....  .........TLT has the cure for cancer... ................ the stock will be fine.... ........................screaming buy at these prices.
Comment by N0taP00p on Nov 13, 2023 3:23pm
@gebremeskel: What changed from October when you said it's hard to interpret the BTD submission timeline based on the last NR?   A small cash infusion would help, certainly,  but only if the timeline is not too far out.  Right?  Maybe you're thinking it's a short window to submission and approval.  If so, it's an assumption but still a risk.  ...more  
Comment by Dumbeldorfwhite on Nov 13, 2023 3:59pm
"We won't need any more raises they said they have the trial paid for" is all we heard for years
Comment by riverrrow on Nov 13, 2023 9:10pm
Of course the covid lockdown slowed down the trial study by one or two years and then the dosage miscalculation.  Expect the unexpected.  In the meantime let's dream the next two unexpected events are BTD and a 10% JV for $300 million.  TLT management is pretty good at keeping stuff close to the vest so who knows what's in the works and when it will happen.  GLTA.  ...more  
Comment by Dumbeldorfwhite on Nov 13, 2023 10:29pm
10% JV for 3000 million hahahahahahaha that's the best thing I heard all night, maybe in 2017 when there were less players in the space
Comment by gebremeskel on Nov 13, 2023 7:00pm
Nothing has changed. We still need to hear from the company about the status of the BTD application. But we are are very close to definitive "best in class" data. What genuine investor would be talking about selling off our IP when we are so close? They have probably already raised enough money to get us over the hump. You don't sell off your seed stock unless you're giving up ...more  
Comment by N0taP00p on Nov 13, 2023 8:04pm
Fair enough. I was just speaking from experience with a company that ended up doing just that, though they were not as far into the FDA process as TLT is.  Will leave it at that. My "soft bashing"  ends here. Will wait to see what happens with the raise and clarification we get on timelines with the quarter-end update expected soon.
Comment by TriumphSpitSix on Nov 13, 2023 10:00pm
For what it's worth, I've personally never considered you a basher, but more of a realist. There's a difference between raising important issues and asking the hard questions on the one hand, and actively working to damage the company or the SP by spreading false information and fear-mongering on the other. I put you in the former category, myself, and I think it's an important ...more  
Comment by N0taP00p on Nov 14, 2023 12:14am
Thanks Triumph. Nothing you can do about the lack of logic or reasoning here. But I understand the desperation as well. We all want to see some returns.   I think Benedictus summed it up well in this thread.  May tomorrow be something other than Groundhog Day.  We deserve it. 
Comment by Longholder99 on Nov 13, 2023 8:07pm
I use the ignore function to negate the comments that make no sense or are clear bashers.
Comment by StevenBirch on Nov 13, 2023 8:24pm
The fear mongering always starts around this time of the month when we are expecting an update, without fail, and the financing just gives them more fodder. They can't do anything about the data though, it is advancing and let's see what they have to say about BTD.
Comment by Dumbeldorfwhite on Nov 13, 2023 3:58pm
My investment is down almost 50%.... are we supposed to be happy?
Comment by TriumphSpitSix on Nov 13, 2023 5:13pm
This is textbook DCA time but the boiler room shorts are trying to push the narrative that the company is on the brink of bankruptcy or some other ridiculous fiction. LMAO, bring in the clowns! Thanks for the laughs. The selling AFAICT, is from some holders taking advantage of the financing w/ free warrants. I'm happy to just grab cheap shares on TD at 12-15 cents (TLTFF) myself as others ...more  
Comment by Benedictus on Nov 13, 2023 11:45pm
I've added some shares recently and I am on the bid for a few more because the data is very good and getting stronger with each update. I am not buying aggressively, however, despite what I believe to be a significantly undervalued asset because my confidence in the science and lack of confidence in management keeps me only cautiously optimistic. I imagine a similar logic is playing out ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250